Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Lang

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nature Reviews. Drug Discovery|February 2, 2022
Identification of neoantigens for individualized therapeutic cancer vaccinesFranziska Lang, Barbara Schrörs, Martin Löwer, et al.
Expert Opinion on Drug Discovery|August 27, 2016
Mouse models for pre-clinical drug testing in leukemiaSanil Bhatia, Svenja Daschkey, Franziska Lang, et al.
Nature Reviews. Drug Discovery|December 12, 2023
Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccinesFranziska Lang, Barbara Schrörs, Martin Löwer, et al.
Biological Chemistry|May 14, 2016
Insights into K-Ras 4B regulation by post-translational lysine acetylationPhilipp Knyphausen, Franziska Lang, Linda Baldus, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 15, 2011
Cervical and vaginal cancer in a woman with chronic graft-versus-host diseaseDaniele Bolla, Thomas Ruhstaller, Pierre-André Diener, et al.
Archives of Gynecology and Obstetrics|November 27, 2012
Bilateral transient osteoporosis of the knee during pregnancyTheodosia Charpidou, Franziska Lang, Thomas Langenegger, et al.
Bioinformatics (Oxford, England)|May 10, 2021
NeoFox: annotating neoantigen candidates with neoantigen featuresFranziska Lang, Pablo Riesgo-Ferreiro, Martin Löwer, et al.
Iscience|November 15, 2023
Multiple instance learning to predict immune checkpoint blockade efficacy using neoantigen candidatesFranziska Lang, Patrick Sorn, Barbara Schrörs, et al.
Human Vaccines & Immunotherapeutics|February 7, 2022
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer ImmunotherapyArne Billmeier, Krutika Khinvasara, Franziska Lang, et al.
Frontiers in Immunology|June 13, 2024
Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapyAlla Bulashevska, Zsófia Nacsa, Franziska Lang, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nature Reviews. Drug Discovery|February 2, 2022
Identification of neoantigens for individualized therapeutic cancer vaccinesFranziska Lang, Barbara Schrörs, Martin Löwer, et al.
Expert Opinion on Drug Discovery|August 27, 2016
Mouse models for pre-clinical drug testing in leukemiaSanil Bhatia, Svenja Daschkey, Franziska Lang, et al.
Nature Reviews. Drug Discovery|December 12, 2023
Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccinesFranziska Lang, Barbara Schrörs, Martin Löwer, et al.
Biological Chemistry|May 14, 2016
Insights into K-Ras 4B regulation by post-translational lysine acetylationPhilipp Knyphausen, Franziska Lang, Linda Baldus, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 15, 2011
Cervical and vaginal cancer in a woman with chronic graft-versus-host diseaseDaniele Bolla, Thomas Ruhstaller, Pierre-André Diener, et al.
Archives of Gynecology and Obstetrics|November 27, 2012
Bilateral transient osteoporosis of the knee during pregnancyTheodosia Charpidou, Franziska Lang, Thomas Langenegger, et al.
Bioinformatics (Oxford, England)|May 10, 2021
NeoFox: annotating neoantigen candidates with neoantigen featuresFranziska Lang, Pablo Riesgo-Ferreiro, Martin Löwer, et al.
Iscience|November 15, 2023
Multiple instance learning to predict immune checkpoint blockade efficacy using neoantigen candidatesFranziska Lang, Patrick Sorn, Barbara Schrörs, et al.
Human Vaccines & Immunotherapeutics|February 7, 2022
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer ImmunotherapyArne Billmeier, Krutika Khinvasara, Franziska Lang, et al.
Frontiers in Immunology|June 13, 2024
Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapyAlla Bulashevska, Zsófia Nacsa, Franziska Lang, et al.
Pageof 3